Navigation Links
Asthma & Allergy Foundation CEO Appointed to NIH Council
Date:1/9/2009

BETHESDA, Md., Jan. 10 /PRNewswire-USNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announces that its President and CEO, William M. McLin, has been appointed to the Council of the National Institute of Allergy and Infectious Disease (NIAID), an institute of the National Institutes of Health (NIH), for a four-year term. The Council is a chartered advisory committee that provides a diverse perspective on science, health and the human impact of diseases.

The Council serves as NIAID's main advisory body on key functions, including: performing peer review, advising on policy, reviewing programs, and developing and clearing concepts for program announcements, requests for applications and requests for proposals. NIAID often seeks the Council's advice before changing policies for training, health information dissemination, administration, budget and other areas.

McLin has been head of AAFA since 2001 at a time when asthma and allergic diseases in the U.S. have experienced alarming growth; prevalence has nearly doubled over the past 25 years. McLin helped the 55-year-old not-for-profit patient group transition into the 21st Century to better educate patients and caregivers, as well as advocate and conduct research for the asthma and allergy community.

McLin will serve on the advisory subcommittee of the Division of Allergy, Immunology, and Transplantation through October 31, 2012. During program reviews, the subcommittee advises on a program's effectiveness in meeting Institute goals and the needs of the allergy and immunology community.

Before coming to AAFA, McLin served as Director of Government Relations and Executive Vice President during his 20-year tenure with the Epilepsy Foundation of America. He also provided interim executive oversight services to numerous nonprofit organizations. Mr. McLin has held key positions with the National Health Council, the American Society of Association Executives, the President's Committee for Employment of People with Disabilities and the Public Advisory Roundtable of the American Thoracic Society.

NIAID conducts and supports basic and applied research to better understand, treat and prevent infectious, immunologic and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people around the world. Visit www.niaid.nih.gov.

AAFA is the leading national not-for-profit patient advocacy organization for people with asthma and allergies. It is dedicated to improving the quality of life for people with asthma and allergies through education, advocacy and research. For more information, visit www.aafa.org.


'/>"/>
SOURCE The Asthma and Allergy Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nitric Oxide Monitoring of Little Benefit for Kids Asthma
2. NO help: Nitric oxide monitoring does not help most children with asthma
3. American Asthma Foundation Announces Breakthrough Discovery
4. Antifungal Drug May Help Ease Asthma
5. Fungal pill could provide asthma relief for 150,000 UK sufferers
6. Anti-fungal drug offers great benefits to some with severe asthma
7. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
8. School Program Helps Cut Asthma Risks
9. Antacid Medication in Pregnancy May Increase Childhood Asthma
10. Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant
11. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting ... and company to wait until March 2017 for an interest rate increase, according to ... College of Business. , “The Federal Open Market Committee (FOMC) dot charts are of ...
(Date:5/26/2016)... Missouri (PRWEB) , ... May 26, 2016 , ... ... quality and clinical outcomes, hosted members and suppliers for its inaugural Member Conference ... focus on their mission of elevating the operational health of America’s healthcare providers. ...
(Date:5/26/2016)... Pompano Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... Green House® Project offering a new model of care for living and ... on three core values: Meaningful Life in a Real Home provided by Empowered Staff. ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... in Korea to support the company’s continued investment and strategic growth plans in ...
(Date:5/26/2016)... ... 26, 2016 , ... Memorial Day Weekend marks the unofficial start of summer ... tips to make sure your family and vehicle are ready to hit the road ... be 439 deaths and an additional 50,500 serious injuries from motor vehicle crashes during ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... Tenn. , May 26, 2016 /PRNewswire/ ... of software and analytics, network solutions and ... today announced it entered into a strategic ... provider of outpatient software solutions and revenue ... centers, specialty hospitals and rehabilitation clinics to ...
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
Breaking Medicine Technology: